Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty
Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the effectiveness of Sublingual Sufentanil Tablets System
(SSTS, Zalviso ®) to control postoperative pain after total knee arthroplasty in the context
of early rehabilitation program.
SSTS is a novel patient controlled analgesia system wich does not require intravenous access,
potentially improving pain control and promoting mobilization.
SSTS will be randomly compared to nurse-driven oral Oxycodone.